Cargando…

Correction: Predicting progression of Alzheimer's disease

Detalles Bibliográficos
Autores principales:	Doody, Rachelle S, Pavlik, Valory, Massman, Paul, Rountree, Susan, Darby, Eveleen, Chan, Wenyaw
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919694/ https://www.ncbi.nlm.nih.gov/pubmed/20470369 http://dx.doi.org/10.1186/alzrt38

Ejemplares similares

Predicting progression of Alzheimer's disease
por: Doody, Rachelle S, et al.
Publicado: (2010)

Factors that influence survival in a probable Alzheimer disease cohort
por: Rountree, Susan D, et al.
Publicado: (2012)

Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
por: Rountree, Susan D, et al.
Publicado: (2009)

Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease
por: Doody, Rachelle S., et al.
Publicado: (2015)

Progress in understanding variability in cognitive responses to cholinesterase inhibitor treatment
por: Pavlik, Valory N, et al.
Publicado: (2011)

Validity, Significance, Strengths, Limitations, and Evidentiary Value of Real-World Clinical Data for Combination Therapy in Alzheimer's Disease: Comparison of Efficacy and Effectiveness Studies
por: Atri, Alireza, et al.
Publicado: (2012)

Cognitively-Related Basic Activities of Daily Living Impairment Greatly Increases the Risk of Death in Alzheimers Disease
por: Liang, Fu-Wen, et al.
Publicado: (2016)

Correction: A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease
Publicado: (2014)

Connecting Cohorts to Diminish Alzheimer’s Disease (CONCORD-AD): A Report of an International Research Collaboration Network
por: Pavlik, Valory N., et al.
Publicado: (2022)

Correction to: Complement in the pathogenesis of Alzheimer’s disease
por: Paul Morgan, B.
Publicado: (2018)

Author Correction: Predicting Alzheimer’s disease progression using multi-modal deep learning approach
por: Lee, Garam, et al.
Publicado: (2023)

Correction: [(18)F]ROStrace detects oxidative stress in vivo and predicts progression of Alzheimer’s disease pathology in APP/PS1 mice
por: Hsieh, Chia-Ju, et al.
Publicado: (2023)

Correction: New Insights into Alzheimer's Disease Progression: A Combined TMS and Structural MRI Study
Publicado: (2014)

Author Correction: History and progress of hypotheses and clinical trials for Alzheimer’s disease
por: Liu, Pei-Pei, et al.
Publicado: (2019)

Correction: Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non‑rapidly progressive Alzheimer’s disease
por: Herden, Janne Marieke, et al.
Publicado: (2023)

Alzheimer’s disease progression by geographical region in a clinical trial setting
por: Henley, David B, et al.
Publicado: (2015)

Correction: The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
por: Craddock, Travis J. A., et al.
Publicado: (2012)

Correction: The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
por: Craddock, Travis J. A., et al.
Publicado: (2012)

Correction: The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
por: Craddock, Travis J. A., et al.
Publicado: (2013)

Correction: GWAS on family history of Alzheimer’s disease
por: Marioni, Riccardo E., et al.
Publicado: (2019)

Modeling the course of Alzheimer's disease to improve clinical trials: symposium report
por: Spiegel, René, et al.
Publicado: (2013)

Correction: Allopregnanolone Preclinical Acute Pharmacokinetic and Pharmacodynamic Studies to Predict Tolerability and Efficacy for Alzheimer's Disease
Publicado: (2015)

Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
por: Ortner, Marion, et al.
Publicado: (2020)

Correction to: Peripheral immune system in aging and Alzheimer’s disease
por: Cao, Wei, et al.
Publicado: (2018)

Correction to: Knock-on effect of periodontitis to the pathogenesis of Alzheimer’s disease?
por: Leblhuber, Friedrich, et al.
Publicado: (2020)

Correction to: New approaches to symptomatic treatments for Alzheimer’s disease
por: Cummings, Jeffrey
Publicado: (2021)

Correction: Diagnostic and prognostic performance to detect Alzheimer’s disease and clinical progression of a novel assay for plasma p-tau217
por: Groot, Colin, et al.
Publicado: (2022)

Correction: Glaucoma, Alzheimer's Disease, and Parkinson's Disease: An 8-Year Population-Based Follow-Up Study
por: Lin, I-Chan, et al.
Publicado: (2016)

Correction: How Statins May Protect against Alzheimer Disease
Publicado: (2012)

Correction: Single-Subject Grey Matter Graphs in Alzheimer's Disease
por: Tijms, Betty M., et al.
Publicado: (2013)

Correction to: Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
por: Wang, Xue, et al.
Publicado: (2020)

Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2023)

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
por: Ostrowitzki, Susanne, et al.
Publicado: (2018)

Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease
por: Ritchie, Craig W., et al.
Publicado: (2018)

Correction: Aberrant iPSC-derived human astrocytes in Alzheimer’s disease
por: Jones, V. C., et al.
Publicado: (2019)

Correction to: Probability of Alzheimer’s disease based on common and rare genetic variants
por: Escott-Price, Valentina, et al.
Publicado: (2021)

Correction: Parp mutations protect from mitochondrial toxicity in Alzheimer’s disease
por: Yu, Yizhou, et al.
Publicado: (2021)

Associations Between Vascular Diseases and Alzheimer’s Disease or Related Dementias in a Large Cohort of Men and Women with Colorectal Cancer
por: Du, Xianglin L., et al.
Publicado: (2022)

Correction to: Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease
por: Fu, Hongyan, et al.
Publicado: (2023)

Author Correction: Untargeted lipidomics reveals progression of early Alzheimer’s disease in APP/PS1 transgenic mice
por: Zhang, Xueju, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i39dqed9bh4ahrp7nqvqusggkf